Why the study?
Does FAT/CD36 relocation contribute to myocardial triacylglycerol accumulation and altered LCFA uptake in cardiac myocytes from obese Zucker rats?
Population
Cardiac myocytes from lean and obese Zucker rats
Comparison
In vitro administration of insulin, oligomycin… vs Basal conditions and comparison between lean and…
Design
Preclinical
Authors
Loading...
Does not inform clinical targeting yet; leaves open FAT/CD36 inhibition for human myocardial steatosis.
Does FAT/CD36 relocation contribute to myocardial triacylglycerol accumulation and altered LCFA uptake in cardiac myocytes from obese Zucker rats?
Permanent relocation of FAT/CD36 to the sarcolemma in cardiac myocytes of obese Zucker rats drives myocardial triacylglycerol accumulation and cellular insulin resistance.
Coort et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: